1 Cooling after cardiac arrest From evidence to clinical practice Jan Martner SIR Presenterat vid SFAI-mötet september 2011.

Slides:



Advertisements
Similar presentations
Trauma Associated Severe Hemorrhage (TASH)-Score: Probability of Mass Transfusion as Surrogate for Life Threatening Hemorrhage after Multiple Trauma The.
Advertisements

Targeted Temperature Management TTM-trial investigators
CONSENSUS: Cooperative North Scandinavian Enalapril Survival Study Purpose To determine whether the ACE inhibitor enalapril reduces mortality in patients.
Dallas 2015 TFQO: David Stanton COI 328 EVREVs: Volker Wenzel COI 253& Emmanuelle Bourdon COI 333 Taskforce: BLS Passive ventilation techniques.
The role of continuous EEG in therapeutic hypothermia
1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.
In a patient who has sustained blunt trauma who is found to have an occult pneumothorax on CT scan, is tube thoracostomy better than observation at reducing.
ESH 2004 Paris1 Blood Pressure Control by Home Monitoring A Meta-Analysis of Randomised Trials FP Cappuccio, SM Kerry, L Forbes, A Donald Published in:
Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.
Loop diuretics VS venous ultrafiltration in cardio-renal syndrome Radek Debiec SHO Renal Medicine LGH Sept 2013.
Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.
INCLUSION/EXCLUSION CRITERIA 1. The following are considerations when defining the cardiac arrest trial patient population (i.e., the inclusion/exclusion.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
THERAPEUTIC HYPOTHERMIA Heike Geduld August 2007.
Pain Agitation & Delirium SCCM Pain assessment i. We recommend that pain be routinely monitored in all adult ICU patients (+1B). ii. The Behavioral.
Therapeutic Hypothermia in Out of Hospital Cardiac Arrest towards
Intensive versus Conventional Glucose Control in Critical Ill Patients N Engl J Med 2009; 360: 雙和醫院 劉慧萍藥師.
Raj Nichani Blackpool Victoria Hospital.  Strengthen collaboration across the region  Spread good practice  Develop on the tremendous potential that.
1 Statin treatment is associated with improved prognosis in patients with AF-related stroke G. Ntaios, V. Papavasileiou, K.Makaritsis, A.Karagiannaki,
Nicolai Haase, MD, PhD Department of Intensive Care Copenhagen University Hospital - Rigshospitalet Resuscitating sepsis – how I do it after 6S 4th International.
Ruchika Husa, MD OSU Wexner Medical Center SCD and Therapeutic Hypothermia.
How to Analyze Therapy in the Medical Literature (part 2)
Monthly Journal article review: Vimmi Kang PGY 2
Dallas 2015 TFQO: Anne-Marie Guerguerian # 97 EVREV1: Anne-Marie Guerguerian # 97 EVEREV2: Ericka Fink # 83 Taskforce: PEDS Peds 407 : ECMO for pediatric.
Analysis Section Research Design. Protocol Overview Background4-5 pages Question/Objective/Hypothesis4 lines Design4-20 lines Study Population0.5-1 page.
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
{ Challenges in cost-utility analysis in the critical care setting Ville Pettilä MD, PhD, A/P Helsinki University Hospital VP SFAI- veckan.
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit The SAFE Study Investigators N Engl J Med 2004: 350:
ITU Journal Club: Dr. Clinton Jones. ST4 Anaesthetics.
Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.
Long-term functional deficiencies of ICU-acquired weakness: a prospective study I Patsaki, G Sidiras, V Gerovasili, A Kouvarakos, E Polimerou, G Mitsiou,
Chicago 2014 TFQO: Charles Deakin #329 EVREV 1: Asger Granfeldt COI #63 EVREV 2: Bo Lofgren COI #363 Taskforce: ALS ALS 571 : Ventilation strategy post-ROSC.
Dallas 2015 TFQO: Allan de Caen COI #38 EVREV 1: Tia Raymond COI #153; EVREV 2: Jonathan Egan COI #44 Taskforce: Peds The role of invasive vascular monitoring.
Dallas 2015 TFQO: Kee-Chong Ng (#COI = 170) EVREV 1: Gene Ong (#COI = 118) EVREV 2: Jos Bruinenberg (#COI = 19) Taskforce: Pediatric Taskforce The Long.
Dallas 2015 TFQO: Vinay Nadkarni #375 EVREV 1: Vinay Nadkarni #375 EVREV 1: Dave Kloeck #126 Taskforce: Paeds Paed 424: Vasopressors in Paediatric cardiac.
TFQO: Jasmeet Soar #COI 272 EVREV 1: Jasmeet Soar #COI 272 EVREV 2: Michael Donnino #COI 222 Taskforce: ALS ALS 448 OXYGEN DOSE AFTER ROSC IN ADULTS 3.
Tuesday’s breakfast Int. 林泰祺. Introduction Maxillofacial injuries in isolation or in combination with other injuries account for a significant percentage.
Copenhagen University Hospital Rigshospitalet, Denmark
Dallas 2015 TFQO: Monica Kleinman COI #353 EVREV 1: Janice Tijssen COI#232 EVREV 2: Javier Urbano COI#240 Taskforce: Peds Peds 815: Pediatric goal-directed.
Dallas 2015 TFQO: Judith Finn EVREVs: Judith Finn #227 / Dion Stub #COI Taskforce: EIT Cardiac Arrest Centres.
Dallas 2015 TFQO: Jan Jensen COI #115 EVREV: Michael Reilly COI #193 Taskforce: First Aid First Aid 768: Use of Tourniquet.
Safety of Albumin Revisited Blood Products Advisory Committee Meeting March 17, 2005 Laurence Landow MD, FRCPC.
Dallas 2015 TFQO: Robert Greif EVREVs: Dana Edelson, COI #334 Robert Greif, COI #344 Taskforce: EIT EIT 645: Debriefing of resuscitation performance.
LINC Trial LUCAS in cardiac arrest trial. What is LINC? A multicenter, randomized, controlled trial designed to evaluate the efficacy and safety of: LUCAS.
Introduction Therapeutic hypothermia has been shown to improve survival and neurologic outcome in patients resuscitated after ventricular fibrillation.
Induced Hypothermia After VF Cardiac Arrest Improves Outcomes Summary and Comment by Kristi L. Koenig, MD, FACEP Published in Journal Watch Emergency Medicine.
Do IV Meds Matter in Out-of-Hospital Cardiac Arrest? Summary and Comment by John A. Marx, MD, FAAEM Published in Journal Watch Emergency Medicine December.
Circulatory System Devices Panel Questions for Discussion EMBOL·X Aortic Filter October 23, 2002.
Dallas 2015 TFQO: Name EVREVs: Names and #COI Taskforce: Name Insert Short PICO title Total of 12 (no studies) to 20 slides (maximum) using standard format.
C. Pretty, A. Le Compte, J. G. Chase, G. Shaw, S. Penning, J-C Preiser, T. Desaive Introduction  Insulin sensitivity defines the metabolic balance between.
Dallas 2015 TFQO: Jonathan Witt (COI #418) EVREVs: Steve Lin (COI #137), Thomas Pellis (COI #186) and Katie Dainty (COI #) Taskforce: ALS ALS 428 : Antiarrhythmic.
Chicago 2014 TFQO: Clifton Callaway # EVREV 1: Janice Zimmerman # EVREV 2: Jonathan Sullivan COI # Taskforce: ALS ALS 790 : Induced Hypothermia.
Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function R3 김동연 /Prof. 정경환 N Engl J Med 373;5 July 30, 2015.
< 회기-강동 합동 컨퍼런스> Systemic Inflammatory Response Syndrome criteria in Defining Severe sepsis Kirsi-Maija Kaukonen, M.D., Ph.D., Michael Bailey, Ph.D.,
Cardiac Arrest: Audit of practice in ICU from 1 st August 2014 to 31 st January 2015 Dr C Hickey and Dr Elizabeth Little.
Towards Global Eminence K Y U N G H E E U N I V E R S I T Y j 내과 R2 이지영.
Pharmacist Impact on Patient Mortality and Advanced Cardiac Life Support Guideline Compliance During In-Hospital Cardiac Arrest Joseph Cavanaugh, PharmD.
CHEST 2013; 144(3): R3 김유진 / Prof. 장나은. Introduction 2  Cardiovascular diseases  common, serious comorbid conditions in patients with COPD cardiac.
Dallas 2015 TFQO: Jasmeet Soar #COI 409 EVREV 1: Jasmeet Soar #COI 409 EVREV 2: Anthony Lagina #COI 357 Taskforce: ALS ALS 889 OXYGEN DOSE DURING CPR IN.
Dallas 2015 TFQO: Michael Donnino #222 EVREV 1: Joshua Reynolds COI #265 EVREV 2: Katherine Berg COI #10 Taskforce: ALS ALS 790 : Induced Hypothermia.
Targeted temperature management at 33⁰c vs 36⁰c after cardiac arrest
CODE FREEZE Svetlana Taylor, Eden Thompson, Jenny Vandiver
Treating Vasodilatory Shock in the ICU
European Heart Association Journal 2007 April
ALPS Trial design: Patients with adult nontraumatic out-of-hospital cardiac arrest (OOHCA) and persistent or recurrent VT/VF after ≥1 shock were randomized.
What is LINC? A multicenter, randomized, controlled trial
Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival  T. Jared Bunch, MD, Stephen C. Hammill, MD, Roger.
Claudio Sandroni a,., Giorgia Ferro a,
We should continue treating on 10 year risk
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

1 Cooling after cardiac arrest From evidence to clinical practice Jan Martner SIR Presenterat vid SFAI-mötet september 2011

2 Out-of hospital cardiac arrest Hospital ER ICU CCU/Ward Survivors In-hospital cardiac arrest /year

3 Out-of hospital cardiac arrest Hospital ER ICU CCU/Ward Survivors In-hospital cardiac arrest Year 2010 n=1222 SIR 2011

4 ICU Out-of hospital admission In-hospital admission Year % 60% SIR 2011

5 Out-of hospital cardiac arrest Hospital ER ICU CCU/Ward 404 (33%) Survivors In-hospital cardiac arrest Longterm (180 days) Outcome 2010 n= (67%) SIR 2011

6 N=275

7

8

9

10 N Engl J Med N=77

11 Results  Improved neurological outcome  Mortality: TH 51% vs no-TH 68% (ns.)

12 ILCOR recommendation: Resuscitation Unconscious adult patients with spontanous circula- tion after out-of-hospital cardiac arrest should be cooled to o C for h when the initial rythm was ventricular fibrillation (VF). Such cooling may also be beneficial for other rythms or in-hospital arrest.

13 SBU's appraisal of the evidence The scientific evidence is insufficient* to show that treatment with induced hypothermia after resuscitation from cardiac arrest improves survival or lowers the risk for permanent functional impairment. Although the scientific evidence is too weak to support reliable conclusions, the method appears to be promising and potentially may be of clinical importance. However, it is essential to continue testing this method in Sweden under scientifically acceptable conditions so that its benefits, risks, and cost effectiveness can be assessed. Until adequate scientific evidence is available, therapeutic hypothermia should be used only within the framework of well-designed, prospective, and controlled trials. Alert report from SBU 2006

Original publications in N Engl J M Start of Hypothermia Network Registry Recommended use by ILCOR Alert report From SBU Report from Hypothermia Network Registry published

15

16 Results  From 2004 until patients were reported the Hypothermia Network  50 % of the patients had a longterm survival  > 90 % had good neurological function

Original publications in N Engl J M Widespread use of TH in Sweden Start of Hypothermia Network Registry Recommended use by ILCOR Alert report From SBU Report published from HNR SIR 10 year anniversery SIR was born

18 Proportion of ICU patients with cardiac arrest receiving hypothermia treatment :

19 Proportion of hypothermia treatment according to hospital type

20 Proportion of patient recieving hypothermia treatment according to region

21 Proportion of patient recieving hypothermia treatment vs total number of cardiac arrest patients per ICU

22 Active cooling after cardiac arrest Out-of-hospital 2010 (N=791)

23 Why was the introduction of TH after cardiac arrest so rapid ?  Contrary to drugs no official approval was required  No substantial extra costs except increased LOS in the ICU  An effective tool to improve outcome after cardiac arrest was much desired  ILCOR recommended TH  Group pressure ??  Perhaps intensivists are more bold and impatient regarding introduction of new methods than other doctors ????

24 Can the results from the RCTs  with a very high degree of patient selection  with strict protocols  and performed in dedicated ICUs be replicatet in a widespread ”real life” use with broader inclusion criteria ?

25 Tabell 1 - Jämförelse av patienter med och utan aktiv hypotermi Activ hypothermiaNo aktiv hypothermia P-value Number of patients1398 (36.1 %)2520 (64.3 %) Age, mean (SD)64.1 (15.6) år67.2 (16.8) år<0.001 (t-test) Gender (Male/Female) 70.4 / 29.6 %62.8 / 37.2 %<0.001 (Chi 2 -test) Risk of death (Apache), mean (SD) (16.7) % N= (22.9) % N=1294 <0.001 (t-test) LOS ICU, median (IQR) 88 (55-141) tim30 (9-74) tim<0.001 (t-test) Surviving patients 30 days after ICU admission 41.3 % 30.7 % <0.001 (Chi 2 -test) a bedömt enligt APACHE-systemet (8) Comparison of patients with or without activ hypothermia

26 Case study II: Active cooling after out-of-hospital cardiac arrest SIR data from

27 Registry studies vs RCT  Data quickly available  Reflects ”real life” conditions  Can easily be combined with other registry data

Original publications in N Engl J M Start of Hypothermia Network Registry Recommended use by ILCOR Alert report From SBU Report from Hypothermia Network Registry published Start of TTM trail The use of TH is based on more solid data ?

29 Conclusions  TH was rapidly introduced in Swedish ICUs in spite of effects not being fully scientifically proven  There are no differences between different types of hospitals regarding introduction and use of TH although there are large differences between individual ICUs  There are minor regional differences regarding the use of TH  ICUs admitting many patients after cardiac arrest show more conformity in the use of TH  A national quality registry with good cover is a valuable tool to monitor introduction of new therapeutic strategies  Survival (30 days) ”in real life” was higher after TH perhaps indicating a positive effect of TH